Company Legal Name
Latest Valuation
Founded Year
Headquarter
Freed Inc. operates an AI-powered medical scribe platform that automates clinical documentation for outpatient healthcare providers. The company's solution captures and transcribes patient-physician conversations, generating structured clinical notes to reduce administrative burden on medical professionals. Founded in 2022 and headquartered in Santa Rosa, California, Freed addresses the growing challenge of physician burnout and documentation inefficiencies in healthcare settings. The platform leverages advanced natural language processing to understand medical terminology and clinical workflows, positioning itself within the expanding AI healthcare automation market. Freed continues to focus on refining its documentation accuracy and expanding provider adoption.
Revenue & Revenue Growth Share
Revenue
Revenue Growth
Available in most regions; subject to local regulations.
Open to non-accredited investors with KYC/AML compliance. U.S. investors must meet SEC requirements.
$10 per token, enabling fractionalized access to Pre-IPO shares.
Mandatory identity (KYC) and proof of funds checks.
Variable, applied to investment amounts.
Charged on realized profits.
Tokens may be locked for 6–12 months; resale depends on secondary market liquidity.
Prices reflect past funding rounds, not guaranteed future value.
Biotech depends on regulatory approvals; fintech faces evolving digital asset rules.
Blockchain or custodian issues could delay transfers or verification.
Changing laws may affect tradability or taxation.





